Dr. Jonathan Kwok

Dr. Jonathan Kwok is a clinician scientist and Cancer Research UK (CRUK) cancer vaccines fellow at the University of Oxford, whose career spans oncology, vaccinology, clinical trials, strategy consulting, and investment banking — an unusually broad foundation for a biotech founder. He completed his DPhil at Merton College, Oxford, where his research into precision immunomics formed the scientific bedrock for a new class of cancer vaccines.

In 2021, Jonathan co-founded Infinitopes Precision Immunomics alongside Dr. Lian Ni Lee and Dr. Senthil Chinnakannan, assembling a world-class team of antigen discovery specialists, T-cell immunologists, computational biologists, and regulatory experts at Oxford's BioEscalator innovation hub. Under his leadership, the company has grown from three academic co-founders to a full clinical-stage organisation, raising over $35 million and earning recognition from Innovate UK, the MHRA, and Cancer Research Horizons.

Infinitopes' lead vaccine candidate, ITOP1, targets oesophageal cancer and in 2025 received MHRA Clinical Trial Application approval to begin a landmark Phase I/IIa clinical trial across four NHS university cancer centres — the first precision cancer vaccine of its kind to reach human trials from Oxford University. Jonathan's mission is to develop accessible, off-the-shelf vaccines that prevent cancer recurrence in patients worldwide.